NFKB1 and Alzheimer disease: Enhanced NF-κB activity in resident glial cells might lead to increased levels of inflammatory cytokines in the brain and is thought to drive the neurotoxicity seen in chronic neurodegenerative disorders such as Alzheimer's disease or Parkinson's disease [53].